Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Thrombosis Research
|
July 10, 2021
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study
Xavier Deschênes-Simard, Corentin Richard, Loïck Galland, et al.
Genes & Development
|
April 20, 2013
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Xavier Deschênes-Simard, Marie-France Gaumont-Leclerc, Véronique Bourdeau, et al.
Leukemia & Lymphoma
|
August 12, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Andrée-Anne Pelland, Xavier Deschênes-Simard, Xavier Savard, et al.
Nature Cell Biology
|
June 27, 2018
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
Frédéric Lessard, Sebastian Igelmann, Christian Trahan, et al.
Haematologica
|
December 24, 2025
Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis
Ronit Marcus, Abraham Avigdor, Uri Greenbaum, et al.
Blood Advances
|
August 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Thrombosis Research
|
July 10, 2021
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study
Xavier Deschênes-Simard, Corentin Richard, Loïck Galland, et al.
Genes & Development
|
April 20, 2013
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Xavier Deschênes-Simard, Marie-France Gaumont-Leclerc, Véronique Bourdeau, et al.
Leukemia & Lymphoma
|
August 12, 2024
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Andrée-Anne Pelland, Xavier Deschênes-Simard, Xavier Savard, et al.
Nature Cell Biology
|
June 27, 2018
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
Frédéric Lessard, Sebastian Igelmann, Christian Trahan, et al.
Haematologica
|
December 24, 2025
Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis
Ronit Marcus, Abraham Avigdor, Uri Greenbaum, et al.
Blood Advances
|
August 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, et al.
Page
of 2